[go: up one dir, main page]

AR059079A1 - Procedimiento cosmetico fotodinamico y metodo de cicatrizacion - Google Patents

Procedimiento cosmetico fotodinamico y metodo de cicatrizacion

Info

Publication number
AR059079A1
AR059079A1 ARP070100229A AR059079A1 AR 059079 A1 AR059079 A1 AR 059079A1 AR P070100229 A ARP070100229 A AR P070100229A AR 059079 A1 AR059079 A1 AR 059079A1
Authority
AR
Argentina
Prior art keywords
collagen
photosensitizer
pdt
liposomal
treatment
Prior art date
Application number
Other languages
English (en)
Original Assignee
Ceramoptec Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceramoptec Ind Inc filed Critical Ceramoptec Ind Inc
Publication of AR059079A1 publication Critical patent/AR059079A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42—Colour properties
    • A61K2800/43—Pigments; Dyes
    • A61K2800/434—Luminescent, Fluorescent; Optical brighteners; Photosensitizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81—Preparation or application process involves irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Transplantation (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se proveen innovadores métodos no quirurgicos y composiciones para administrar PDT para promover regeneracion o aumento de tejido mientras que se minimiza la formacion de cicatrices y el riesgo de infeccion. Entre varias áreas de aplicacion, está el tratamiento de heridas agudas y cronicas las cuales han castigado estratos de tejido epidérmico y conectivo del cuerpo. Otra área de aplicacion es como tratamientos/cirugías cosméticos, incluyendo: reducir arrugas, surcos, cicatrices (de acné o por causa traumática), celulitis de secuela, así como también para otras irregularidades de piel, para dar una superficie de piel más lisa. La presente consta de una matriz de soporte basada en colágeno u otra adecuada biodegradable la cual es embebida con un fotosensibilizador con carga liposomal. En una realizacion de la presente, un fotosensibilizador formulado liposomal es inyectado primero en el sitio seguido por implantacion de colágeno y tratamiento de PDT. En otra realizacion se incorpora un fotosensibilizador formulado liposomal en el colágeno. Generalmente 30 minutos después de mezclado el colágeno con el fotosensibilizador se hace la activacion por luz. La matriz también puede portar importantes factores de crecimiento y citoquinas, los cuales promueven la migracion y la proliferacion de células de fibroblasto, al sitio de la herida. También se puede controlar la infeccion microbiana en el sitio de la herida mediante PDT antibacteriano.
ARP070100229 2006-01-18 2007-01-18 Procedimiento cosmetico fotodinamico y metodo de cicatrizacion AR059079A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75966006P 2006-01-18 2006-01-18
US11/650,207 US8999933B2 (en) 2006-01-18 2007-01-05 Photodynamic cosmetic procedure and healing method

Publications (1)

Publication Number Publication Date
AR059079A1 true AR059079A1 (es) 2008-03-12

Family

ID=38263442

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070100229 AR059079A1 (es) 2006-01-18 2007-01-18 Procedimiento cosmetico fotodinamico y metodo de cicatrizacion

Country Status (6)

Country Link
US (1) US8999933B2 (es)
EP (1) EP1983965B1 (es)
AR (1) AR059079A1 (es)
ES (1) ES2446490T3 (es)
TW (1) TWI397411B (es)
WO (1) WO2007084468A2 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070031482A1 (en) * 2005-08-02 2007-02-08 Ceramoptec Industries, Ind. PDT treatment method for cellulites and cosmetic use
PL1951184T3 (pl) 2005-11-09 2012-06-29 Valeant Pharmaceuticals Int Inc Kompozycje do wybielania zębów i sposoby
US20070212385A1 (en) * 2006-03-13 2007-09-13 David Nathaniel E Fluidic Tissue Augmentation Compositions and Methods
US20100266989A1 (en) * 2006-11-09 2010-10-21 Klox Technologies Inc. Teeth whitening compositions and methods
US20080214460A1 (en) * 2007-01-18 2008-09-04 Ceramoptec Industries, Inc. Formulations for cosmetic and wound care treatments with photosensitizers as fluorescent markers
EP2214784A4 (en) * 2007-10-03 2012-12-26 Gen Hospital Corp PHOTOCHEMICAL TISSUE CONNECTION
US8475815B2 (en) 2007-10-29 2013-07-02 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
US8431141B2 (en) * 2007-10-29 2013-04-30 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
US8709395B2 (en) 2007-10-29 2014-04-29 Ayman Boutros Method for repairing or replacing damaged tissue
US7910134B2 (en) * 2007-10-29 2011-03-22 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
GB2469219A (en) * 2008-04-10 2010-10-06 Kythera Biopharmaceuticals Inc Dermal filler composition
DK2365829T3 (en) 2008-11-07 2017-07-31 Klox Tech Inc COMBINATION OF AN OXIDANT AND PHOTO ACTIVATOR FOR HEALING OF WOES
US8597284B2 (en) * 2009-06-03 2013-12-03 Biolitec Pharma Marketing, Ltd. Cosmetic rejuvenation by photodynamic therapy
EP2453922B1 (en) 2009-07-17 2017-10-25 Klox Technologies Inc. Antibacterial oral composition
CA2794254C (en) 2010-03-22 2018-09-04 Allergan, Inc. Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
US8815228B2 (en) 2010-04-30 2014-08-26 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
US20130281913A1 (en) 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
US11116841B2 (en) 2012-04-20 2021-09-14 Klox Technologies Inc. Biophotonic compositions, kits and methods
NZ701667A (en) 2012-05-30 2017-05-26 Klox Tech Inc Compositions and methods for biophotonic bone reconstruction
US20140011980A1 (en) * 2012-07-03 2014-01-09 Allergan, Inc. Methods for sterilizing compositions and resulting compositions
JP6231570B2 (ja) 2012-09-14 2017-11-15 ヴァレアント ファーマシューティカルズ インターナショナル インコーポレイテッドＶａｌｅａｎｔ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ， Ｉｎｃ． 歯のホワイトニングのための組成物および方法
US20140276354A1 (en) 2013-03-14 2014-09-18 Klox Technologies Inc. Biophotonic materials and uses thereof
MX366292B (es) 2013-07-03 2019-07-04 Klox Tech Inc Composiciones biofotónicas que comprenden un cromóforo y un agente gelificante para el tratamiento de heridas.
RU2016142722A (ru) * 2014-04-01 2018-05-04 Клокс Текнолоджиз Инк. Композиции наполнителей для тканей и способы их применения
WO2016065488A1 (en) 2014-10-31 2016-05-06 Klox Technologies Inc. Photoactivatable fibers and fabric media
US10183174B2 (en) 2015-06-22 2019-01-22 Quantum Dynamics, LLC Device for providing body temperature regulation and/or therapeutic light directed to vasculature
CN119185653A (zh) 2018-05-03 2024-12-27 科尔普兰特有限公司 真皮填充剂和其应用
US20210046163A1 (en) * 2019-08-12 2021-02-18 Bioregentech, Inc. Therapeutic systems, devices, and compositions with wound healing and tissue regenerative properties, uses thereof, and corresponding methods
KR102397253B1 (ko) * 2020-01-20 2022-05-13 한국과학기술연구원 세균 및 진균의 감소 및 사멸을 위한 광역학 반응용 조성물, 및 이를 이용한 항균 조성물, 항진균 조성물, 살균 조성물 및 살균방법
CN114949337B (zh) * 2022-05-11 2023-11-21 上海交通大学 医用温敏性水凝胶敷料及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5785051A (en) * 1980-11-18 1982-05-27 Toppan Printing Co Ltd Water-soluble photosensitive material
US4947840A (en) * 1987-08-21 1990-08-14 Massachusetts Institute Of Technology Biodegradable templates for the regeneration of tissues
US6231881B1 (en) * 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
US5552452A (en) * 1993-03-15 1996-09-03 Arch Development Corp. Organic tissue glue for closure of wounds
US5716404A (en) * 1994-12-16 1998-02-10 Massachusetts Institute Of Technology Breast tissue engineering
US5913884A (en) * 1996-09-19 1999-06-22 The General Hospital Corporation Inhibition of fibrosis by photodynamic therapy
ATE270114T1 (de) * 1997-02-11 2004-07-15 Quadra Logic Tech Inc Zusammensetzungen und gegenstände zur verminderung der auswirkung von entzündungen
US6165205A (en) * 1998-07-10 2000-12-26 Ceramoptec Industries, Inc. Method for improved wound healing
ATE335513T1 (de) * 1998-10-16 2006-09-15 Gen Hospital Corp Photosensitizer-konjugate zur zielrichtung von intrazellulare pathogene
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
US6527764B1 (en) * 1999-12-02 2003-03-04 Ceramoptec Industries, Inc. Device and method for laser biomodulation in PDT/surgery
US8215314B2 (en) * 2000-02-11 2012-07-10 The General Hospital Corporation Photochemical tissue bonding
GB0005855D0 (en) * 2000-03-10 2000-05-03 Scotia Holdings Plc Compounds for pdt
US6607522B1 (en) * 2000-03-16 2003-08-19 General Hospital Corporation Methods for tissue welding using laser-activated protein solders
WO2001085213A2 (en) * 2000-05-08 2001-11-15 The University Of British Columbia Supports for photosensitizer formulations
GB0018527D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Composition
DE10316566A1 (de) * 2003-04-10 2004-10-28 Haemato-Science Gmbh Mittel für die photodynamische Diagnostik und Therapie von bösartigen Tumoren
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy
RU2253424C1 (ru) * 2004-02-10 2005-06-10 Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Способ хирургического формирования первичной подвижной опорной культи и фотодинамической терапии после энуклеации глаза по поводу опухоли
US8709449B2 (en) * 2004-02-12 2014-04-29 Biolitec Pharma Marketing Ltd Methods and compositions for improving photodynamic therapy through administration of lipids
RU2269985C1 (ru) * 2004-06-22 2006-02-20 Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Министерства здравоохранения Российской Федерации Способ фотодинамического лечения инфекционных язв роговицы
CA2589367C (en) * 2004-12-21 2015-02-03 Laboratoires Serono S.A. Sulfonyl amino cyclic derivatives and use thereof
US20090012211A1 (en) * 2007-07-02 2009-01-08 David Abecassis Novel biodegradable nanocomposites

Also Published As

Publication number Publication date
WO2007084468A2 (en) 2007-07-26
EP1983965A2 (en) 2008-10-29
US8999933B2 (en) 2015-04-07
EP1983965A4 (en) 2009-06-24
EP1983965B1 (en) 2013-11-06
ES2446490T3 (es) 2014-03-07
WO2007084468A3 (en) 2007-11-22
TWI397411B (zh) 2013-06-01
US20070166369A1 (en) 2007-07-19
TW200803845A (en) 2008-01-16

Similar Documents

Publication Publication Date Title
AR059079A1 (es) Procedimiento cosmetico fotodinamico y metodo de cicatrizacion
Yeh et al. Light-emitting diodes—Their potential in biomedical applications
WO2004075985A3 (en) Cosmetic or therapeutic methods and apparatus
US9737728B2 (en) Method for the treatment of mammalian skin tissues via pulse irradiation in the presence of a photoactive compound
Pinheiro et al. Polarized light (400–2000 nm) and non-ablative laser (685 nm): a description of the wound healing process using immunohistochemical analysis
Sharma et al. Scar revision
US20100137950A1 (en) System and method for the photodynamic treatment of burns, wounds, and related skin disorders
JP2017509433A5 (es)
JP2017509433A (ja) 組織充填剤組成物および使用方法
AU2015318541A1 (en) Emissive polymeric matrices
Park et al. The effects of 830 nm light-emitting diode therapy on acute herpes zoster ophthalmicus: a pilot study
Colić et al. The use of polarized light in aesthetic surgery
Safonov Atlas of scar treatment and correction
Yadav et al. Effects of Photobiomodulation Adjunct Therapy via Superpulsed 904 nm Laser in Patients With Second‐Degree Burns: Randomized Controlled Clinical Trial
US20240424061A1 (en) Methods and compositions for skin repair, rejuvenation and comfort
Weijie et al. Intense pulsed light therapy
US20220168552A1 (en) Straberi EpiStamp Device
US20230226369A1 (en) Use of blue light for induction of angiogenesis
CN110650753A (zh) 用于伤口愈合的光化学处理方法
Ryu et al. Comparison of the 660 nm and 532 nm wavelengths for photobiomodulation therapy on dermal wounds in mice
US20220266051A1 (en) Wearable biophotonic systems
Calderhead 27 Skin Aging Clock and Its Resetting by Light-Emitting Diode Low-Level Light Therapy
Sehgal et al. Nail biology, morphologic changes, and clinical ramifications: part II
Sawhney et al. Low-Level Laser (Light) Therapy for Cosmetics and Dermatology
Safonov Atrophic scars and stretch marks

Legal Events

Date Code Title Description
FB Suspension of granting procedure